JPS5841813A - Emulsion external agent composition containing stably mixed vitamin a - Google Patents

Emulsion external agent composition containing stably mixed vitamin a

Info

Publication number
JPS5841813A
JPS5841813A JP14056381A JP14056381A JPS5841813A JP S5841813 A JPS5841813 A JP S5841813A JP 14056381 A JP14056381 A JP 14056381A JP 14056381 A JP14056381 A JP 14056381A JP S5841813 A JPS5841813 A JP S5841813A
Authority
JP
Japan
Prior art keywords
vitamin
emulsion
antioxidant
composition containing
agent composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP14056381A
Other languages
Japanese (ja)
Other versions
JPH0244806B2 (en
Inventor
Katsuki Awamura
粟村 勝樹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sunstar Inc
Original Assignee
Sunstar Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sunstar Inc filed Critical Sunstar Inc
Priority to JP14056381A priority Critical patent/JPH0244806B2/en
Publication of JPS5841813A publication Critical patent/JPS5841813A/en
Publication of JPH0244806B2 publication Critical patent/JPH0244806B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/671Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/522Antioxidants; Radical scavengers

Abstract

PURPOSE:The titled composition, containing vitamin A, an antioxidant, e.g. di- tert-butylhydroxytoluene, butylhydroxyanisole or tocopherol, and EDTA salt, and having a stabilizing effect on the vitamin A for a long term. CONSTITUTION:An emulsion skin external agent composition containing vitamin A, 0.001-0.5%, based on the total composition, antioxidant, e.g. di-tert-butylhydroxytoluene, butylhydroxyanisole or tocopherol, and 0.001-0.5% EDTA salt as an emulsion medicinal pharmaceutical, quasi-drug or cosmetic, e.g. an emulsion, cream, aerosol or pack. The use of the specific antioxidant and EDTA salt improves the stability of the vitamin A remarkably without causing the problem such as the coloring of the system. 0.01-0.5%, based on the total composition, vitamin A palmitate or acetate is used as the vitamin A.

Description

【発明の詳細な説明】 本発明はビタミンAを安定に配合した乳化系皮膚外用剤
組成物、さらに詳しくは、ビタミンAを安定に配合した
クリーム、乳液のような皮膚外用の乳化系医薬製剤、医
薬部外品および化粧品に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to an emulsion-based skin external preparation composition stably containing vitamin A, more specifically, an emulsion-based skin external pharmaceutical preparation such as a cream or a milky lotion stably containing vitamin A; Regarding quasi-drugs and cosmetics.

従来から、皮膚外用剤の有効成分として各種のビタミン
類が用いられており、ビタミンAも皮膚角化症等の予防
、治療に有効な成分であることが知られている。一方、
脂溶性ビタミンであるビタミンAは水の非存在下では比
較的安定であるが、水の存在下ではきわめて酸化されや
すく、非常に不安定であることが知られている。
Conventionally, various vitamins have been used as active ingredients in external skin preparations, and vitamin A is also known to be an effective ingredient in the prevention and treatment of skin keratosis and the like. on the other hand,
Vitamin A, which is a fat-soluble vitamin, is relatively stable in the absence of water, but is extremely susceptible to oxidation and is known to be extremely unstable in the presence of water.

かくして、従来から、乳化系の皮膚外用剤にもビタミン
Aが配合されているが、そのビタミンAは系中に存在す
る水のためにきわめて不安定であり、経時と共に速かに
酸化されてその効力を失い、系中に長期にわたってビタ
ミンAを安定に保持することが困難である。しかし、か
かる乳化系におけるビタミンAの安定化について、従来
、あまり検討がなされておらず、未だ、乳化系の皮膚外
用剤においてビタミンAを安定に配合できる有効な手段
は見当らない。
For this reason, vitamin A has traditionally been included in emulsified skin preparations, but vitamin A is extremely unstable due to the water present in the system, and is rapidly oxidized over time. It loses its efficacy, making it difficult to stably retain vitamin A in the system over a long period of time. However, the stabilization of vitamin A in such an emulsion system has not been studied much in the past, and no effective means for stably incorporating vitamin A into an emulsion system for external use on the skin has yet been found.

このような事情にかんがみ、本発明者 は乳化系の皮膚
外用剤におけるビタミンAの安定化について鋭意検討を
重ねた。
In view of these circumstances, the present inventors have conducted extensive studies on stabilizing vitamin A in emulsified skin preparations.

まず、ビタミンAの配合方法により安定化を図るべく種
々検討したが、安定性の向上は見られなかった。つぎに
、ビタミンAの酸化を防ぐべく、各種の抗酸化剤の使用
、また、抗酸化剤と、そのシネルギストとして知られる
ウルトラリン酸、クエン酸、アスコルビン酸、ソルビッ
ト、各種アミノ酸との併用を試みたが、かえって、ビタ
ミンAの酸化生成物や抗酸化剤、シネルギスト自体に由
来すると考えられる系の著しい着色が生じ、やはり、充
分満足すべき安定性の向上は見られなかった。ところが
、意外にも、ある種の抗酸化剤とエチレンジアミン四酢
酸塩(以下、EDTA塩という)を併用するとビタミン
Aの安定性が著しく向上し、かつ、系の着色という問題
も生じないことが判明した。
First, various studies were conducted to stabilize the product by changing the method of blending vitamin A, but no improvement in stability was observed. Next, in order to prevent the oxidation of vitamin A, we tried using various antioxidants, and combined antioxidants with synergists such as ultraphosphoric acid, citric acid, ascorbic acid, sorbitol, and various amino acids. However, on the contrary, significant coloration occurred in the system, which was thought to be derived from the oxidation products of vitamin A, the antioxidant, and the synergist itself, and no sufficiently satisfactory improvement in stability was observed. However, surprisingly, it was found that when a certain type of antioxidant is used in combination with ethylenediaminetetraacetate (hereinafter referred to as EDTA salt), the stability of vitamin A is significantly improved, and the problem of coloration of the system does not occur. did.

本発明はかかる知見に基いて完成されたものであって、
ビタミンAを有効成分とする乳化系皮膚外用剤組成物に
おいて、ジ−t−ブチルヒドロキシトルエン(以下、B
HTという)、ブチルヒドロキシアニソール(以下、B
HAという)およびトコフェロールからなる群から選ば
れる抗酸化剤およびEDTA塩を配合したことを特徴と
するビタミンAを安定に配合した乳化系皮膚外用剤組成
物を提供するものである。本発明においては、EDTA
塩も一種の抗酸化剤のシネルギストと考えられるが、そ
の作用機序は明らかではなく、前記のごとき従来汎用さ
れるシネルギストと異なり、系の着色などの問題を生ぜ
ず、該抗酸化剤と共にビタミンAの酸化を効果的に防止
し、乳化系の皮膚外用剤に配合されたビタミンAの長期
安定化を図ることができる。
The present invention was completed based on such knowledge, and
In an emulsified skin external preparation composition containing vitamin A as an active ingredient, di-t-butylhydroxytoluene (hereinafter referred to as B
HT), butylhydroxyanisole (hereinafter referred to as B
The present invention provides an emulsified skin preparation composition stably containing vitamin A, which is characterized by containing an antioxidant selected from the group consisting of HA) and tocopherol, and EDTA salt. In the present invention, EDTA
Salt is also considered to be a kind of antioxidant synergist, but its mechanism of action is not clear, and unlike the conventionally used synergists mentioned above, it does not cause problems such as coloring of the system, and it can be used with vitamins and antioxidants. Oxidation of vitamin A can be effectively prevented and long-term stabilization of vitamin A contained in emulsified skin preparations can be achieved.

つぎに、乳液に配合したビタミンAに対する各種の抗酸
化剤、シネルギストの安定化効果を試験した結果を示す
Next, the results of testing the stabilizing effects of various antioxidants and synergists on vitamin A blended into the emulsion are shown.

試験方法 後記の処方に従い、ビタミンAパルミテートおよび各種
の抗酸化剤および/またはシネルギストを配合した種々
の乳液を調製し、40℃で1ケ月保存後、各乳液中のビ
タミンA単位数を定量し、配合当初のビタミンA単位数
に対する残存率(%)を算出した。また、同時に乳液の
着色度合を肉眼で評価した。
Test method Various emulsions containing vitamin A palmitate and various antioxidants and/or synergists were prepared according to the prescriptions described below, and after storage at 40°C for one month, the number of vitamin A units in each emulsion was determined. The residual rate (%) with respect to the initial number of vitamin A units was calculated. At the same time, the degree of coloring of the emulsion was visually evaluated.

乳液処方 成 分              重量%香 料  
              適量この処方に従い、A
の各成分を混合し、約75℃で加温溶解し、これを、約
75℃に加温したBの各成分混合物に加え、よく攪拌し
、冷却し、ついで香料を加えて乳液を得た。
Emulsion prescription ingredients Weight% Fragrance
Follow this recipe in an appropriate amount,
Each component was mixed and dissolved by heating at about 75°C, and this was added to the mixture of each component of B heated to about 75°C, stirred well, cooled, and then perfume was added to obtain an emulsion. .

ビタミンAパルミテートの定量はつぎのとおり行なった
Quantification of vitamin A palmitate was performed as follows.

乳液試料的109を精秤し、クロロホルム−エタノール
(1:1)混液約80艷に溶解した。これを沖過し、同
じ混液で稀釈して100dとし、試料溶液として用いた
Emulsion sample No. 109 was accurately weighed and dissolved in about 80 g of a chloroform-ethanol (1:1) mixture. This was filtered and diluted with the same mixture to make 100 d, which was used as a sample solution.

別途、あらかじめビタミンA単位数を測定したビタミン
Aパルミテート標準品約10■を精秤し、クロロホルム
−エタノール(1: 1 )混液テ100−とし、これ
を標準溶液として用いた。
Separately, approximately 10 μm of a standard vitamin A palmitate product whose number of vitamin A units had been measured in advance was accurately weighed to prepare a chloroform-ethanol (1:1) mixed solution, which was used as a standard solution.

これらの試料溶液および標準溶液を、各々、20−のル
ープ式計量管に注入し、高速液体クロマトグラフィーに
付した(島津製作所製、高速液体クロマト装置Lc−1
、カラム:ヌクレオシルC−1C−18(25φ4 m
 )、移動相:メタノール、カラム温度:35℃、流速
:1.Oi/分、検出波長:320nm)。得られたク
ロマトグラム中のビタミンAパルミテートのピーク高さ
を測定し、試料溶液のピーク高さをA【、標準溶液のピ
ーク高さをAs とし、次式に従って試料溶液中のビタ
ミンA単位数を求めた。
These sample solutions and standard solutions were each injected into a 20-loop measuring tube and subjected to high performance liquid chromatography (high performance liquid chromatography device Lc-1 manufactured by Shimadzu Corporation).
, Column: Nucleosil C-1C-18 (25φ4 m
), mobile phase: methanol, column temperature: 35°C, flow rate: 1. Oi/min, detection wavelength: 320 nm). Measure the peak height of vitamin A palmitate in the obtained chromatogram, set the peak height of the sample solution as A[, the peak height of the standard solution as As, and calculate the number of vitamin A units in the sample solution according to the following formula. I asked for it.

結果をつぎの第1表に示す。なお、対照として抗酸化剤
、シネルギスト無添加の乳液について同様に試験した結
果も示す。また、第1表中における着色はつぎの基準に
従って評価した。
The results are shown in Table 1 below. As a control, the results of a similar test on a milky lotion without the addition of an antioxidant or synergist are also shown. Moreover, the coloring in Table 1 was evaluated according to the following criteria.

○:着色なし 轟:やや着色気味 ×:着色 ×X:ややひどい着色 ××X:ひどい着色 xxxx :非常に着色 第1表 第1表(つつき) 注)−二配合せず。○: No coloring Todoroki: Slightly colored ×: Coloring ×X: Somewhat severe coloring XXX: Severe coloring xxxx: Very colored Table 1 Table 1 (pecking) Note) - Two combinations are not included.

第1表に示すごとく、EDTA塩と抗酸化剤を併用した
場合にのみ、40℃、1ケ月の保存の後にも着色を起す
ことなく、70%以上もの高いビタミンA残存率を保持
することができる。なお、BHAもBHTと同様な傾向
を示した。
As shown in Table 1, only when EDTA salts and antioxidants are used together can a high vitamin A residual rate of over 70% be maintained without coloring even after storage at 40°C for one month. can. Note that BHA also showed the same tendency as BHT.

かくして、本発明の皮膚外用剤組成物は0/W型、W2
O型いずれの乳化系でもよく、有効成分としてビタミン
Aを配合し、前記の抗酸化剤およびEDTA塩の併用に
よりその安定化を図るものである。
Thus, the skin external preparation composition of the present invention is 0/W type, W2 type.
Any O-type emulsification system may be used, and vitamin A is blended as an active ingredient, and the above-mentioned antioxidant and EDTA salt are used in combination to stabilize the emulsion system.

用いるビタミンAとしては、ビタミンAパルミテート、
ビタミンAアセテート等、通常この種組成物に配合され
るものいずれでもよく、配合量は実際の組成物の剤形、
所望の薬効等により適宜選択できるが、一般に、組成物
全量に対して0.01〜0.5%(重量呪、以下同じ)
程度が好ましい。
The vitamin A used is vitamin A palmitate,
Vitamin A acetate, etc., may be used, and the amount to be added will depend on the dosage form of the actual composition,
It can be selected as appropriate depending on the desired medicinal effect, etc., but in general, it is 0.01 to 0.5% (by weight, the same applies hereinafter) based on the total amount of the composition.
degree is preferred.

抗酸化剤はBHT、BHA、  トコフェロールいずれ
でもよく、第1表から明らかなごとく、安定化効果が高
い点でBHTが好ましい。トコフェロールには種々の異
性体があるが、本発明においては特に限定するものでは
なく、d、/、d/ 一体いずれでもよく、また、α、
β、γ、δ一体いずれでもよい。さらに、これらの混合
物やトコフェロールの混合物として知られるビタミンE
なども用いることができる。なお、トコフェロールと他
の抗酸化剤を組合せると、かえって酸化を促進するので
、そのような抗酸化剤の混合使用はさけるべきである。
The antioxidant may be BHT, BHA, or tocopherol, and as is clear from Table 1, BHT is preferred because it has a high stabilizing effect. There are various isomers of tocopherol, but in the present invention, they are not particularly limited, and may be either d, /, d/, α,
Either β, γ, or δ may be integrated. In addition, vitamin E, known as a mixture of these and tocopherols,
etc. can also be used. Note that combining tocopherol with other antioxidants will actually promote oxidation, so mixed use of such antioxidants should be avoided.

抗酸化剤の配合量も適宜選択できるが、一般に、組成物
全量に対して0.001〜0.5係程度が望ましい。
Although the amount of the antioxidant can be selected as appropriate, it is generally desirable to use an amount of about 0.001 to 0.5 with respect to the total amount of the composition.

EDTA塩としては、EDTA−1ナトリウムEDTA
−2ナトリウム、EDTA−3ナトリウム、EDTA−
4ナトリウムなどが用いられ、通常、組成物全量に対し
て0.001〜0,5%程度が望ましい。
As the EDTA salt, EDTA-1 sodium EDTA
-2-sodium, EDTA-3-sodium, EDTA-
4-sodium is used, and it is usually desirable to use it in an amount of about 0.001 to 0.5% based on the total amount of the composition.

本発明の皮膚外用剤組成物は、常法に従って、乳液、ク
リーム、エアゾール、パックのような乳化系の剤形の医
薬製剤、医薬部外品、化粧品に調製することができ、他
の配合成分は特に限定するものではなく、通常用いられ
るものいずれでもよい。ことに、油相成分中に、トリカ
プリル酸グリセリド、トリ(2−エチルヘキサン酸)グ
1ノセ1ノドのような中鎖のトリグリセリドやイ゛ノセ
チJレイソステアレート、イソプロピルイ゛ノステアレ
ート、2−エチルヘキサン酸セチル、イソプロピルツマ
ルミテート ンチルグリコールのようなエステル油を多く添カロする
とビタミンAの安定性向上唇こさら各こ効果力くあるこ
とが判明しており、これらを油相1こ用しすることが好
ましい。
The skin external preparation composition of the present invention can be prepared into pharmaceutical preparations, quasi-drugs, and cosmetics in the form of emulsions such as milky lotions, creams, aerosols, and packs according to conventional methods, and other ingredients. is not particularly limited, and may be any commonly used one. In particular, the oil phase components contain medium-chain triglycerides such as tricaprylic acid glyceride, tri(2-ethylhexanoic acid) glyceride, isopropylene monostearate, isopropyl monostearate, It has been found that adding a large amount of ester oils such as cetyl 2-ethylhexanoate and isopropyltumalmitatetonyl glycol has the effect of improving the stability of vitamin A and softening the lips. It is preferable to use this method.

つぎに実施例を挙げて本発明をさらに詳しく説明する。Next, the present invention will be explained in more detail with reference to Examples.

実施例1 栄養クリーム 成 分              重量%香 料  
             適量この処方に従い、Aの
各成分を混合し、約75℃で加温溶解し、これを、約7
5℃に加温したRの各成分混合物に加え、よく攪拌し、
冷却し、ついで香料を加えてビタミンAを安定に配合し
た栄養クリームを得た。
Example 1 Nutritional Cream Ingredients Weight % Fragrance
According to this recipe, mix appropriate amounts of each component of A, heat and dissolve at about 75°C, and add about 75°C.
Add to the mixture of each component of R heated to 5°C, stir well,
The mixture was cooled and then flavoring was added to obtain a nutritional cream stably containing vitamin A.

実施例2 乳液 成 分              重量%香 料  
              適量この処方に従い、前
記実施例1と同様にしてビタミンAを安定に配合した乳
液を得た。
Example 2 Emulsion ingredient Weight% fragrance
An emulsion containing a stable amount of vitamin A was obtained in the same manner as in Example 1 according to this prescription.

実施例3 乳液 成 分              重量%F、DTA
−2す)+Jウム        0.02香 料  
             適量この処方に従い、前記
実施例1と同様にしてビタミンAを安定に配合した乳液
を得た。
Example 3 Emulsion components Weight % F, DTA
-2su)+Jum 0.02Fragrance
An emulsion containing a stable amount of vitamin A was obtained in the same manner as in Example 1 according to this prescription.

実施例4 コールドクリーム 成分      重量% 香料               適量この処方lこ
従い、前記実施例1と同様1こしてビタミンAを安定に
配合したコールドクリームを得た。
Example 4 Cold Cream Ingredients Weight % Perfume Appropriate Amount This formulation was strained in the same manner as in Example 1 to obtain a cold cream containing vitamin A in a stable manner.

特許出願人サンスター株式会社 代理人弁理士青山 葆+9J)−2名Patent applicant Sunstar Co., Ltd. Representative patent attorney Aoyama Ao + 9J) - 2 people

Claims (1)

【特許請求の範囲】[Claims] (1)  ビタミンA配合乳化系皮膚外用剤組成物にお
いて、ジー【−ブチルヒドロキシトルエン、ブチルヒド
ロキシアニソールおよびトコフェロールからなる群から
選ばれる抗酸化剤およびエチレンジアミン四酢酸塩を配
合したことを特徴とするビタミンAを安定に配合した乳
化系皮膚外用剤組成物。
(1) A vitamin A-containing emulsified skin external preparation composition containing an antioxidant selected from the group consisting of di[-butylated hydroxytoluene, butylated hydroxyanisole, and tocopherol] and ethylenediaminetetraacetate. An emulsified skin external preparation composition stably containing A.
JP14056381A 1981-09-07 1981-09-07 BITAMINAOANTEINIHAIGOSHITANYUKAKEIHIFUGAIYOZAISOSEIBUTSU Expired - Lifetime JPH0244806B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP14056381A JPH0244806B2 (en) 1981-09-07 1981-09-07 BITAMINAOANTEINIHAIGOSHITANYUKAKEIHIFUGAIYOZAISOSEIBUTSU

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14056381A JPH0244806B2 (en) 1981-09-07 1981-09-07 BITAMINAOANTEINIHAIGOSHITANYUKAKEIHIFUGAIYOZAISOSEIBUTSU

Publications (2)

Publication Number Publication Date
JPS5841813A true JPS5841813A (en) 1983-03-11
JPH0244806B2 JPH0244806B2 (en) 1990-10-05

Family

ID=15271586

Family Applications (1)

Application Number Title Priority Date Filing Date
JP14056381A Expired - Lifetime JPH0244806B2 (en) 1981-09-07 1981-09-07 BITAMINAOANTEINIHAIGOSHITANYUKAKEIHIFUGAIYOZAISOSEIBUTSU

Country Status (1)

Country Link
JP (1) JPH0244806B2 (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60246307A (en) * 1984-05-22 1985-12-06 Shiseido Co Ltd Oil-in-water type emulsified cosmetic
JPS60246306A (en) * 1984-05-22 1985-12-06 Shiseido Co Ltd Water-in-oil type emulsified cosmetic
EP0184942A2 (en) * 1984-12-14 1986-06-18 Ortho Pharmaceutical Corporation Improved pharmaceutical composition containing 13-CIS vitamin a acid as the active ingredient
US5559149A (en) * 1990-01-29 1996-09-24 Johnson & Johnson Consumer Products, Inc. Skin care compositions containing retinoids
US5583136A (en) * 1990-01-29 1996-12-10 Johnson & Johnson Consumer Products, Inc. Retinoid containing skin care compositions containing imidazoles
JPH1053515A (en) * 1996-08-09 1998-02-24 Ajinomoto Co Inc Skin lotion
EP0608433A4 (en) * 1992-07-13 1998-09-16 Shiseido Co Ltd Composition for dermatologic preparation.
JP2002241279A (en) * 2001-02-16 2002-08-28 Kanebo Ltd Package-containing product and method for preventing adsorption
US6461622B2 (en) 1994-09-07 2002-10-08 Johnson & Johnson Consumer Companies, Inc. Topical compositions
US6531141B1 (en) 2000-03-07 2003-03-11 Ortho-Mcneil Pharmaceutical, Inc. Oil-in-water emulsion containing tretinoin
JP2004315390A (en) * 2003-04-14 2004-11-11 Kose Corp Cosmetic
JP2005132822A (en) * 2003-08-21 2005-05-26 Neutrogena Corp Stabilized composition containing oxygen unstable active agent
JP2006321771A (en) * 2005-05-20 2006-11-30 Basf Japan Ltd Human body aerosol composition comprising vitamin
JP2012036183A (en) * 2010-07-16 2012-02-23 Rohto Pharmaceutical Co Ltd Composition for external use

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60246307A (en) * 1984-05-22 1985-12-06 Shiseido Co Ltd Oil-in-water type emulsified cosmetic
JPS60246306A (en) * 1984-05-22 1985-12-06 Shiseido Co Ltd Water-in-oil type emulsified cosmetic
EP0184942A2 (en) * 1984-12-14 1986-06-18 Ortho Pharmaceutical Corporation Improved pharmaceutical composition containing 13-CIS vitamin a acid as the active ingredient
US5559149A (en) * 1990-01-29 1996-09-24 Johnson & Johnson Consumer Products, Inc. Skin care compositions containing retinoids
US5583136A (en) * 1990-01-29 1996-12-10 Johnson & Johnson Consumer Products, Inc. Retinoid containing skin care compositions containing imidazoles
US5652263A (en) * 1990-01-29 1997-07-29 Johnson & Johnson Consumer Products, Inc. Retinoid compositions containing a water soluble antioxidant and a chelator
USRE38813E1 (en) 1990-01-29 2005-10-04 Johnson & Johnson Consumer Companies, Inc. Retinoid compositions containing a water soluble antioxidant and a chelator
US6024941A (en) * 1992-07-13 2000-02-15 Shiseido Company, Ltd. External skin treatment composition
EP0608433A4 (en) * 1992-07-13 1998-09-16 Shiseido Co Ltd Composition for dermatologic preparation.
US6461622B2 (en) 1994-09-07 2002-10-08 Johnson & Johnson Consumer Companies, Inc. Topical compositions
JPH1053515A (en) * 1996-08-09 1998-02-24 Ajinomoto Co Inc Skin lotion
US6531141B1 (en) 2000-03-07 2003-03-11 Ortho-Mcneil Pharmaceutical, Inc. Oil-in-water emulsion containing tretinoin
JP2002241279A (en) * 2001-02-16 2002-08-28 Kanebo Ltd Package-containing product and method for preventing adsorption
JP2004315390A (en) * 2003-04-14 2004-11-11 Kose Corp Cosmetic
JP2005132822A (en) * 2003-08-21 2005-05-26 Neutrogena Corp Stabilized composition containing oxygen unstable active agent
JP2006321771A (en) * 2005-05-20 2006-11-30 Basf Japan Ltd Human body aerosol composition comprising vitamin
JP2012036183A (en) * 2010-07-16 2012-02-23 Rohto Pharmaceutical Co Ltd Composition for external use

Also Published As

Publication number Publication date
JPH0244806B2 (en) 1990-10-05

Similar Documents

Publication Publication Date Title
KR100309399B1 (en) Preparation for epidermis
KR930007911B1 (en) External preparations free of discoloration
JP3103430B2 (en) Fat-soluble antioxidant mixture
JPS5841813A (en) Emulsion external agent composition containing stably mixed vitamin a
JPH0751491B2 (en) Emulsified cosmetics containing crude drugs
JP2822093B2 (en) W / O / W type emulsified cosmetic
JPH0881325A (en) Cosmetic
JPS61130205A (en) Aqueous composition containing stabilized ascorbic acid
JPS6256411A (en) Beautifying agent
JPH0745387B2 (en) Hair growth and hair growth promoter
JP7449692B2 (en) Oil-based external composition
CN114828839A (en) Vitamin A and vitamin C combinations with enhanced stability
JP2589761B2 (en) Cosmetic additives
JPH0525030A (en) Skin cosmetic
KR20100016290A (en) Emulsion preconcentrates and micellar formulations containing wood resins
JP3313148B2 (en) External preparation for skin
JP2020196669A (en) Vitamin b12 photostabilizing method
JPH0899827A (en) Skin external agent
JPH0632710A (en) Skin external preparation
JP2019131524A (en) Cosmetic and skin external preparation
JPH0818963B2 (en) Whitening cosmetics
JP4065647B2 (en) Transparent aqueous base
JP3836051B2 (en) Skin external preparation containing arbutin
JPS62298508A (en) Skin cosmetic
JPS62195316A (en) Dermatic drug